Zymbiotics LLC, headquartered in the United States, is a pioneering company in the biotechnology industry, specialising in innovative microbial solutions. Founded in 2018, Zymbiotics has quickly established itself as a leader in the development of advanced probiotics and enzyme products, catering to both agricultural and health sectors. With a focus on enhancing soil health and promoting sustainable farming practices, Zymbiotics offers unique formulations that improve crop yields and soil vitality. Their commitment to research and development has led to significant milestones, including partnerships with key agricultural organisations. Recognised for their cutting-edge technology and eco-friendly approach, Zymbiotics continues to make strides in the market, positioning itself as a trusted name in microbial innovation.
How does Zymbiotics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pre-Prepared Foods industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zymbiotics's score of 8 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zymbiotics, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Zymbiotics may still be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions profile. In the context of industry standards, many companies are increasingly adopting Science-Based Targets Initiative (SBTi) guidelines and committing to significant reductions in greenhouse gas emissions. However, without specific commitments or data from Zymbiotics, it is unclear how they align with these industry trends. As the company progresses, it may consider establishing measurable targets and reporting frameworks to enhance transparency and accountability in its climate strategy.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zymbiotics has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
